Not exact matches
Representatives from both the scientific and legal communities expressed outrage that
patent rights to
genes could be awarded on the basis of work that provided no insight into
how the
gene might function.
HOW»S this for a brain teaser:
gene patents scrapped last year on the grounds that they were based on natural molecules were last week reinstated on the grounds that the molecules are, after all, unnatural.
The Australian legal jousting comes as that nation's policymakers pursue a trio of initiatives that could have far - reaching implications for
how Australia handles biomedical
patents, including those on human
genes.
Gene patents,
how do you get them and why are they there?
Let me show
how the distinction is both missing and operative in the case of the BRCA1 and BRCA2
gene patents.
«People we've spoken with at Health Canada are delighted because they're grappling with whole exome / whole genome sequencing where you literally sequence a patient's
genes and even one
patent on one mutation could be enough to thwart the power of the test, so they've been happy with the result and looking at
how it might affect them,» he says.